NYLIM
RMD icon

New York Life Investment Management’s ResMed RMD Stock Holding History

New York Life Investment Management’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$5.41M Buy
24,094
+2,349
+11% +$585K 0.05% 312
2025
Q4 		$5.24M Buy
21,745
+313
+1% +$80K 0.05% 315
2025
Q3 		$5.87M Sell
21,432
-474
-2% -$129K 0.05% 305
2025
Q2 		$5.65M Buy
21,906
+75
+0.3% +$17.9K 0.05% 307
2025
Q1 		$4.89M Sell
21,831
-83
-0.4% -$19.4K 0.05% 323
2024
Q4 		$5.01M Buy
21,914
+230
+1% +$55.4K 0.05% 324
2024
Q3 		$5.29M Sell
21,684
-676
-3% -$151K 0.05% 335
2024
Q2 		$4.28M Buy
22,360
+199
+0.9% +$40.4K 0.04% 374
2024
Q1 		$4.39M Sell
22,161
-780
-3% -$143K 0.04% 371
2023
Q4 		$3.95M Sell
22,941
-10,673
-32% -$1.64M 0.04% 378
2023
Q3 		$4.97M Sell
33,614
-1,584
-5% -$286K 0.05% 308
2023
Q2 		$7.69M Sell
35,198
-506
-1% -$113K 0.08% 235
2023
Q1 		$7.82M Buy
35,704
+12,737
+55% +$2.76M 0.09% 235
2022
Q4 		$4.78M Buy
22,967
+1
+0% +$220 0.05% 337
2022
Q3 		$5.01M Sell
22,966
-100
-0.4% -$22.8K 0.06% 306
2022
Q2 		$4.84M Buy
+23,066
New +$4.91M 0.06% 319

Other funds holding RMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
DAM
Diamant Asset Management Ridgefield, Connecticut $147M AUM 25.76% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

New York Life Investment Management's RMD Position: Q1 2026 in Review

New York Life Investment Management increased its ResMed (RMD) stake by 11% in Q1 2026, buying an estimated $585K and bringing the position to 24,094 shares worth $5.41M. The position accounts for 0.05% of the portfolio, ranked #312.

New York Life Investment Management first reported a position in RMD in Q2 2022 and has held it in 16 quarters since. The position peaked at $7.82M in Q1 2023. 940 funds tracked by Wall St. Rank hold RMD as of Q1 2026.

  • New York Life Investment Management held 24,094 shares of ResMed worth $5.41M as of Q1 2026.
  • New York Life Investment Management bought 2,349 ResMed shares in Q1 2026, an estimated $585K.
  • ResMed made up 0.05% of New York Life Investment Management's portfolio in Q1 2026, its #312 holding.
  • New York Life Investment Management first reported a position in ResMed in Q2 2022 and has held it in 16 quarters since.
  • New York Life Investment Management's ResMed position peaked at $7.82M in Q1 2023.
  • 940 funds tracked by Wall St. Rank held ResMed as of Q1 2026.

Based on New York Life Investment Management's 13F filing for Q1 2026, filed 7 May 2026.